Oncocyte Corp posts annual revenue of $958,000 in 2022
Key fundamental financials- loss of $72.90 million
- Revenue of $958,000
By USInMinutes
Published - Apr 12, 2023, 05:01 PM ET
Last Updated - Jul 18, 2023, 03:57 PM EDT
Oncocyte Corp [OCX] has reported $72.90 million loss for the fiscal year ending Dec 31, 2022.
Revenue for the year was $958,000 with operating income of $18 million.
The Alameda, California (CA)-based company operating in the in vitro & in vivo diagnostic substances sector with 76 employees has total shareholders equity of $34.29 million.
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Our Offices
10kInfo, Inc.
13555 SE 36th St
Bellevue, WA 9800610kInfo Data Solutions, Pvt Ltd.
Claywork Create
11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
Bengaluru, Karnataka 560076
4.2 12182024
Popular News
